DiCE Molecules is a privately-held company focused on the development of small molecule compounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. Utilizing its unique approach, DiCE can amplify the strongest potential drug candidates and, by combining massive diversity with amplification and selection, substantially increase the probability of success.
| Website | http://www.dicetherapeutics.com |
| Ticker | DICE |
| Revenue | $8 million |
| Employees | 19 (9 on RocketReach) |
| Founded | 2013 |
| Address | 279 E Grand Ave Ste 300 Lbby B, South San Francisco, California 94080, US |
| Phone | +1 650-566-1402 |
| Fax | (650) 566-1429 |
| Industry | Business Services General, Biotechnology, Business Services, Discovery Tools (Healthcare) |
| Web Rank | 7 Million |
| Keywords | Small Molecule Drugs, Drug Discovery, Therapeutic Development, Pharmaceutical Research, Biotechnology, Drug Development, Oncology, Immunology, Precision Medicine, New Drug Modalities, Undruggable Targets, Biopharma, Pharmaceutical, Life Sciences, Molecular Medicine, Medicinal Chemistry |
| Competitors | Roche, Novartis, Pfizer, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Lilly India +44 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular DiCE Molecules employee's phone or email?
The DiCE Molecules annual revenue was $8 million in 2026.
Rebecca Erickson is the Executive Director, Nonclinical Toxicology of DiCE Molecules.
9 people are employed at DiCE Molecules.
DiCE Molecules is based in South San Francisco, California.
The NAICS codes for DiCE Molecules are [54, 54171, 5417, 541, 541714].
The SIC codes for DiCE Molecules are [87, 873].